# 20 — I02-R3B · Independent Live Outcome Review

**DATE:** 2026-10-19  
**REVIEWED_MAIN_SHA:** `214a3943bc66f4c6a1effed74cb13ffc158dfad5`  
**LIVE_SOURCE_SHA:** `b684264c26f0a770dc93c9e5d650e3c503286412`  
**EVIDENCE:** [19](./19-i02r3b-authenticated-live-outcome-validation.md); Execution Ledger §6.260; earlier decisions [14](./14-i02r3-independent-diagnostic-review-and-architecture-decision.md), [16](./16-i02r3a-independent-experiment-review.md) and [18](./18-i02r3b-independent-implementation-review.md).  
**VERDICT:** `ACCEPT_WITH_RESIDUAL` for the **bounded R3-B typed-merge implementation and recorded live functional outcome**. **I02_ACCEPTED=NO** pending broader requirements/relevance/sufficiency review.

## 1. Reviewed live facts and caveats

Runtime showed R3-B markers in deployed image, model `moonshotai/kimi-k3`, budget=30s, stage timeout=30s, config fingerprint `4e1f9a8aea970e7b`. Deployment was not changed for evaluation; the executor reported regression/full pytest PASS. This coordination review inspected committed documentary evidence and did not independently repeat authenticated calls or tests. Treat logged live outcomes as recorded executor evidence, not an independently reproduced A/B.

- **K1 TÉO:** typed capability+goal proposal (`goal_class=read`), separate `turn_goal` NOT invoked, owner catalog DISCOVERY 91ms, `get_methodology_guide` READ 54ms, total **21,469ms**, grounded method guidance, content 2032 chars, `result_truncated`, no material ACT. `PASS_WITH_LIMITATION`.
- **K2 same-session continuation:** 8,720ms, 12 transformed evidence excerpts, owner not reinvoked, answer **48 chars**, usefulness `PARTIAL`, `prior_turn_evidence_only`, non-grounded continuity classification. Structural continuity PASS; user outcome insufficiently rich for full I02 acceptance.
- **K3 VISTA:** 17,028ms, INDEX with 11 identifiers → topic-selected guidance READ, grounded 1345 chars, exact topic identifier absent in recorded log; relevance remains `PARTIAL`. No material ACT.
- Pre-owner K1 four model calls (group, combined capability+goal, native, arguments); arguments ~10,062ms. This stage is an optimization residual, **not evidence of a new generic architecture need**.
- Historical failing K1 ~30,016ms versus live K1 21,469ms: actual task outcome now succeeded, but different SHA/config and n=1 means **no causal A/B or distribution/p95 claim**.

## 2. Decision

Accept R3-B narrowly as a functional cold-start optimization with real live successful TÉO READ, preserved K2 structural continuity and preserved VISTA nested guidance in sampled tests. Do not declare full adaptive routing algorithm implemented, global I02 accepted, generalized reliability or performance SLA achieved. Do not enable stage cap 10s or experimental arguments guard based on this result.

**Next bounded scope:** product-quality remediation of K2 48-char answer and VISTA topic relevance, prioritizing direct evidence-based correction after code/contract review; keep K1 typed optimization intact. If a user priority is fast K1, arguments model stage may be separately profiled only with outcome-linked evidence. Avoid new broad investigations.

```text
R3B_LIVE_OUTCOME_REVIEW=ACCEPT_WITH_RESIDUAL
K1_LIVE_TASK_OUTCOME=PASS_WITH_LIMITATION
K2_LIVE_STRUCTURAL=PASS_WITH_LIMITATION
K2_USEFULNESS=PARTIAL
K3_NESTED_GUIDANCE=PASS_WITH_LIMITATION
K3_TOPIC_RELEVANCE=PARTIAL
LIVE_A_B_CAUSAL_ATTRIBUTION=INCONCLUSIVE
P95=INCONCLUSIVE
INDEPENDENT_LIVE_REPLAY=TEST_NOT_RUN
I02_ACCEPTED=NO
C3_EXECUTED=NO
C4_AUTHORIZED=NO
C5_AUTHORIZED=NO
NEXT=I02_R3B_K2_K3_OUTPUT_QUALITY_BOUNDED_REMEDIATION
```
